Progressive Care Announces 2021 Audited Financial Report Conference Call and Investor Update on March 28, 2022
Progressive Care Inc. (OTCQB: RXMD) has scheduled an investor conference call for March 28, 2022, at 4:30 PM ET. CEO Alan Jay Weisberg noted that 2021 was a challenging year, but the company completed the pharmacy system implementation and achieved record COVID-19 revenues. The upcoming call will provide shareholders with detailed updates and insights into the company's vision for 2022. Investors can submit questions prior to the call, and access details are provided for those who wish to listen to the live or archived sessions.
- Achieved record COVID-19 revenues in 2021.
- Completed implementation of pharmacy system for growth.
- 2021 was described as a challenging year.
Progressive Care is pleased to announce that the Company has scheduled an investor conference call at 4:30 PM ET on Monday, March 28, 2022.
MIAMI, FL, March 23, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company (the “Company” or “Progressive Care”), is pleased to announce that the Company has scheduled an investor conference call at 4:30 PM ET on Monday, March 28, 2022.
Chairman and CEO, Alan Jay Weisberg, stated, “I believe 2021 was a challenging year for Progressive Care. Our team was able to complete complex implementation of the pharmacy system so that the company can get back to growing the pharmacy business, successfully achieve record COVID-19 revenues and position itself to become an SEC reporting company. We are looking forward to providing our shareholders with a more detailed update and share the Company’s vision for 2022 during the conference call.”
Those attending the investor conference call will have the opportunity to submit questions concerning the Company to Stuart Smith of SmallCapVoice.Com, Inc. via email: ssmith@smallcapvoice.com by 12:00 PM EST on Friday, March 25th, 2022. The Company plans to address as many appropriate questions as possible.
To access the call:
Dial-In Number: 1-857-232-0157
Access Code: 422095
For those unable to participate in the live conference call, a replay will be available at https://www.smallcapvoice.com/clients/rxmd/. shortly after the call has concluded.
An archived version of the webcast will also be available https://progressivecareus.com/news/.
Progressive Care Inc.
Progressive Care Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
For more information about Progressive Care, please visit the company’s website.
Connect and stay in touch with us on social media:
Progressive Care Inc.
https://www.progressivecareus.com/ https://twitter.com/ProgressCareUS
PharmCoRx
https://www.pharmcorx.com/ https://twitter.com/PharmCoRx
ClearMetrX
https://www.clearmetrx.com/ https://www.facebook.com/clearmetrx/
Forward-Looking Statements:
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Public Relations Contact:
Carlos Rangel
carlosr@pharmcorx.com
Investor Relations Contact:
ClearThink Capital
nyc@clearthink.capital
FAQ
When is the Progressive Care conference call?
What was Progressive Care's performance in 2021?
How can I access the Progressive Care conference call?
What updates can investors expect during the conference call?
What is the ticker symbol for Progressive Care?
